Skip to main content
Equibles
HSCS logo

HSCS · HeartSciences Inc. · Metrics

Track HSCS — free

Use HSCS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HSCS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.77 +0.98 (+25.86%)
Rebalance outlook locked
Going-concern doubt — flagged Sep 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors raise substantial doubt regarding the Company's ability to continue as a going concern.”
View the 10-Q filed Sep 14, 2026
Market Cap
$13.80M
Shares
4.80M

HSCS metrics

59 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.79
Market cap
$13.80M

Price action

20 metrics
Price change (1W)
-15.7%
Price change (30D)
+55.7%
Price change (3M)
+82.0%
Price change (6M)
+29.8%
Price change (YTD)
+11.3%
Price change (1Y)
+4.2%
Trailing year
Price change (5Y)
—
52-week high
$4.12
52-week low
$1.67
Change from 52-week high
-16.5%
Change from 52-week low
+106.0%
Annualized volatility
98.7%
Annualized volatility (3M)
151.5%
Beta
0.1
RSI (14D)
58.1
Price vs SMA 50
+28.2%
Price vs SMA 200
+34.9%
Avg volume (3M)
2.31M
Relative volume
0.0
Average dollar volume
$6.36M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
4.80M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3,054.7×
reciprocal yield 0.0%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-74.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-03-16

Profitability

9 metrics
Gross margin
60.9%
Operating margin
-209,733.1%
Trailing 12 months
Net margin
-227,024.2%
Gross profit (TTM)
$2,751
Operating profit (TTM)
−$9.48M
Net income (TTM)
−$10.26M
Trailing 12 months
Diluted EPS (TTM)
$-6.86
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.07

Growth

11 metrics
Revenue growth YoY
+10.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$4,519
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+203.1%
Year over year · more shares
Revenue CAGR (3Y)
-5.7%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-274.5%
Debt / equity
—
Current ratio
0.1
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.1
Interest coverage
-11.8
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$29,906
Latest balance sheet
Cash & equivalents
$29,906
Total assets
$3.74M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$6.79M
Capital expenditures (TTM)
—
R&D (TTM)
$2.75M
SG&A (TTM)
$6.73M
Stock compensation (TTM)
$1.88M
R&D / revenue
60,819.5%
Stock compensation / revenue
41,529.4%

Ownership (13F)

3 metrics
13F filers
17
13F filer change QoQ
+2
Institutional ownership
12.8%

Short interest

3 metrics
Short interest
2.4%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
62 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1468492 CUSIP 42254E302 13F (30d) 1 filings 1 filers Visit website Investor relations